The U.S. Foods and Drug Administration alerted manufacturer-title and generic businesses June 18 a few analysis corporation in India that experienced falsified the data Utilized in critical research to realize approval of its prescription drugs."I do think it raises plenty of questions about the implications for that prescription drugs available,"